MLP Saglik Hizmetleri AS Class B
BBIST:MPARK394.75
TRY
-7.50
(-1.86%)
ISIN
TREMLPC00021
Return %
Stock
S&P 500
1Y
21.27
14.20
3Y
178.19
81.12
5Y
1,449.25
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- CEO
- Muharrem Usta
- Full Time Employees
- 12,940
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Otakçilar Caddesi Flatofis Istanbul, No: 78 Istanbul IB Turkey 3450
- IPO Date
- Feb 13, 2018
- Website
- mlpcare.com
- Similar Companies
- Business
- MLP Saglik Hizmetleri A.S. (MPARK.IS) operates as Turkey's leading private healthcare group, providing comprehensive medical services through its extensive network of hospitals under the Liv Hospital and Medical Park brands; core offerings encompass inpatient and outpatient treatments across specialties including brain and nerve surgery, cardiology, cardiac surgery, gynecology and obstetrics, oncology, orthopedics, physical therapy and rehabilitation, dentistry, check-ups, laboratory services, and ancillary services such as diagnostic imaging, robotic surgery, and medical product trading. The company serves diverse patient segments from middle-upper mass to premium customers, including domestic patients, foreign medical tourists from over 200 countries, and insurance providers, with a portfolio of 36 hospitals exceeding 7,100 beds situated in 13 cities across Turkey, Baku in Azerbaijan, Budapest in Hungary, Pristina in Kosovo, and Dubai. Founded in 1993 and headquartered in Istanbul, Turkey, MLP Saglik Hizmetleri maintains operations through subsidiaries like Livist Saglik Hizmetleri A.S. and various regional health entities, employing over 13,000 staff and emphasizing innovation via AI-driven systems, hybrid operating rooms, university collaborations for research, and JCI-accredited facilities. Recent developments include the June 2025 signing of a protocol to acquire all shares of Bileşim Turizm Inşaat Sanayi ve Ticaret A.S., owner of Özel Gaziosmanpaşa Hastanesi in Istanbul with 403 beds and 60,000 square meters, positioning it as one of the group's highest-capacity assets to bolster inorganic growth; completion of a TRY 2 billion green bond issuance and a TRY 5 billion corporate bond issuance to qualified investors in June 2025 for funding diversification; increase in ownership of MLP Ataşehir Saglik Hizmetleri A.S. to 64% in January 2025 for a new hospital project in Istanbul; temporary suspension of Medical Park Çanakkale Hospital operations in January 2025 due to structural risks post-earthquake analysis, with plans for relocation within 18 months; and a capital reduction finalized in October 2024 reducing issued capital to TL 191 million. In the first half of 2025, revenues grew 10% to TL 24.3 billion, EBITDA rose 9% to TL 6 billion with a 25% margin, driven by 20% Turkish Medical Association tariff hikes and domestic patient volume increases, despite foreign medical tourism softness. The company, formerly known as Medical Park Saglik Hizmetleri A.S., upholds strong corporate governance with investment-grade ratings from JCR Eurasia and sustains a net debt/EBITDA ratio of 0.7x as of June 2025.